The 28[th] of March is the last day of trading in TO 2
The exercise period for Prostatype Genomics AB's ("Prostatype Genomics" or "the Company") warrants of series TO 2 ("TO 2") lasts until March 30, 2023, and the last day for trading in TO 2 is March 28, 2023. Holders of TO 2 have the right to subscribe for one new share in Prostatype Genomics at a price of SEK 2.90 per share for each warrant. An information sheet is available on the respective websites of Prostatype Genomics (www.prostatypegenomics.com), Sedermera Corporate Finance AB (www.sedermera.se) and Nordic Issuing AB (www.nordic-issuing.se).TO 2 in brief · Exercise price: each TO